Glaukos Corp (GKOS)

Glaukos Corp (GKOS) is a Medical Devices company in the Healthcare sector listed on the NYSE.

As of Oct 23, 2026: market cap $10.4B; returns 1 day +1.2%, 1 week +8.5%, 1 year +137.7%.

Glaukos Corporation (NYSE: GKOS) is an ophthalmic pharmaceutical and medical technology company focused on developing and commercializing novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. Glaukos pioneered Micro-Invasive Glaucoma Surgery (MIGS) and continues to develop dropless platform technologies.

Groups GKOS belongs to

• Ophthalmology
• Medical Devices
• Minimally Invasive Surgery
• Healthcare
• Biotechnology
• Pharmaceuticals
• Biopharmaceutical
• Commercial Stage
• Healthcare Equipment
• Healthcare Innovation
• Healthcare Technology

GKOS financial model: income statement, cash flow and balance sheet